Related Experiment Videos

Ph1-positive CML-derived myeloid-monocytoid precursor cell line producing substance(s) that stimulates normal CFU-C

Leukemia Research
|January 1, 1987
PubMed

Insights

A new cell line, KOPM-28, derived from chronic myelogenous leukemia (CML) exhibits myeloid and monocytoid precursor features. These cells stimulate normal hematopoietic progenitor growth, suggesting potential therapeutic applications in CML research.

Area of Science:

  • Hematology
  • Cell Biology
  • Leukemia Research

Background:

  • Established a novel Ph1-chromosome positive cell line, KOPM-28, from a patient with chronic myelogenous leukemia (CML) in blast crisis.
  • Characterized the phenotypic immaturity of KOPM-28 cells, noting the absence of azurophilic granules and myeloperoxidase activity.

Observation:

  • KOPM-28 cells demonstrated positive reactivity for specific and nonspecific esterases, with modulation by TPA and retinoic acid.
  • Cells expressed complement receptors, myeloid-monocytoid antigens, Ia-like antigen, and T4 antigen, but lacked lymphoid and platelet-megakaryocyte specific markers.
  • KOPM-28 cells exhibited colony formation in semi-solid medium, enhanced by GM-CSA, and were not phagocytic.

Findings:

  • KOPM-28 cells possess characteristics of myeloid and monocytoid precursor cells.
  • Culture medium conditioned by KOPM-28 cells significantly increased CFU-C colonies in normal bone marrow cells.
  • These findings suggest KOPM-28 cells produce stimulating factors for normal hematopoietic progenitor cells.

Implications:

  • The KOPM-28 cell line serves as a valuable model for studying CML pathogenesis and blast crisis.
  • The identified stimulating substance(s) produced by KOPM-28 cells warrant further investigation for potential therapeutic strategies in hematological disorders.
  • This research contributes to understanding myeloid differentiation and hematopoietic stem cell regulation.

Related Concept Videos